Replies to post #102625 on Biotech Values

[DewDiligence]

Did ZGEN recruit all new patients for the phase-2b portion of the trial? If not, how many patients were carried over from the phase-2a portion? If yes, why are the phase-2a and phase-2b portions of the trial not considered two distinct trials?